Top compounds associated with response to MARK4


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 5e-05
mRNA vorinostat:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 9e-05
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0003
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.13 0.0004
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.12 0.001
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.001
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA Carboplatin CTRPv2 pan-cancer AAC 0.11 0.002
mRNA STF-31 CTRPv2 pan-cancer AAC 0.11 0.002
Download CSV